Artificial Intelligence in Biomedicine
Artificial Intelligence (AI) in Biomedicine refers to the use of AI technologies, such as machine learning (ML) and deep learning (DL), to analyze and interpret complex biomedical data. In the short term, AI is making significant contributions to healthcare and biomedical research in several key areas:
Key Areas of AI in Biomedicine:
-
Diagnostics: AI algorithms can analyze medical images (e.g., X-rays, MRIs, CT scans) to detect diseases like cancer, pneumonia, and neurological conditions with high accuracy. AI is also used for diagnosing conditions based on genetic data or patient history.
-
Drug Discovery: AI accelerates the drug development process by predicting how different compounds might interact with targets in the body, identifying potential drug candidates faster than traditional methods.
-
Personalized Medicine: AI helps create personalized treatment plans by analyzing a patient’s genetic makeup, medical history, and lifestyle data to recommend the most effective therapies.
-
Predictive Analytics: AI models can predict disease outbreaks, patient deterioration, or future health risks by analyzing patterns in large datasets, including electronic health records (EHR) and wearable device data.
-
Clinical Trials: AI optimizes the design and recruitment processes for clinical trials, identifying suitable candidates and predicting the trial's outcomes based on patient characteristics and historical data.
Related Conference of Artificial Intelligence in Biomedicine
30th International Conference on Neuropharmacology and Neurochemistry
Artificial Intelligence in Biomedicine Conference Speakers
Recommended Sessions
- Advanced Drug Delivery Systems
- Advances in Vaccine Technology
- Advances in Omics Technologies
- Artificial Intelligence in Biomedicine
- Biotechnology in Drug Development
- Cardiovascular Pharmacotherapy
- Clinical Pharmacology and Therapeutics
- Digital Health and Telemedicine
- Ethical Challenges and Regulatory Science in Healthcare and Pharmaceuticals
- Gene Therapy and Genetic Medicine
- Immunotherapy and Immunopharmacology
- Infectious Diseases and Antimicrobial Resistance
- Innovations in Biologics and Biosimilars
- Metabolic Disorders and Endocrinology
- Nanotechnology in Biomedicine
- Neuropharmacology and Neurotherapeutics
- Oncology Research and Therapeutics
- Paediatric and Geriatric Pharmacotherapy
- Pharmacogenomics and Personalized Medicine
- Pharmacovigilance and Drug Safety
- Public Health and Pharmacoeconomics
- Rare and Orphan Diseases: Therapeutic Approaches
- Rare Disease Therapeutics
- Regenerative Medicine and Tissue Engineering
- Respiratory and Pulmonary Pharmacotherapy
Related Journals
Are you interested in
- Artificial Intelligence in Neuropharmacological Drug Discovery - Neuropharmaceutics 2026 (Indonesia)
- Blood-Brain Barrier Pharmacology and Drug Delivery - Neuropharmaceutics 2026 (Indonesia)
- Brain-Computer Interfaces and Neurochemical Modulation - Neuropharmaceutics 2026 (Indonesia)
- Computational and Systems Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
- Digital Biomarkers and Neurochemical Monitoring Technologies - Neuropharmaceutics 2026 (Indonesia)
- Integrating Neurochemistry with Computational Brain Modeling - Neuropharmaceutics 2026 (Indonesia)
- Machine Learning Models in Neurochemical Data Analysis - Neuropharmaceutics 2026 (Indonesia)
- Molecular Mechanisms in Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Basis of Epilepsy and Anticonvulsant Pharmacology - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Basis of Mood Disorders and Emotional Regulation - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Big Data and Cloud-Based Pharmacology Platforms - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Biosensors and Real-Time Brain Monitoring - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Mechanisms in Neurodegenerative Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neurochemical Signaling and Synaptic Transmission - Neuropharmaceutics 2026 (Indonesia)
- Neurochemistry of Addiction and Reward Pathways - Neuropharmaceutics 2026 (Indonesia)
- Neurochemistry of Neuroendocrine Regulation - Neuropharmaceutics 2026 (Indonesia)
- Neurochemistry of Psychiatric and Mood Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neuroimaging Analytics and Computational Mapping of Brain Chemistry - Neuropharmaceutics 2026 (Indonesia)
- Neuroinflammation and Pharmacological Modulation - Neuropharmaceutics 2026 (Indonesia)
- Neuroinformatics and Computational Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacological Approaches to Pain and Analgesia - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacological Approaches to Pain Modulation and Analgesia - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Addiction and Substance Abuse - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Cognitive Function and Memory - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Neurodegenerative Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Neurodevelopmental and Autism Spectrum Disorders - Neuropharmaceutics 2026 (Indonesia)
- Neuropharmacology of Neuroplasticity and Neural Regeneration - Neuropharmaceutics 2026 (Indonesia)
- Neurotransmitter Receptors and Signal Transduction - Neuropharmaceutics 2026 (Indonesia)
- Precision Neuropharmacology through Artificial Intelligence and Genomic Profiling - Neuropharmaceutics 2026 (Indonesia)
- Virtual Drug Screening and Molecular Docking in Neuropharmacology - Neuropharmaceutics 2026 (Indonesia)
